Guardion Health Sciences, Inc. (GHSI) News
Filter GHSI News Items
GHSI News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
GHSI News Highlights
- GHSI's 30 day story count now stands at 4.
- Over the past 9 days, the trend for GHSI's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- GEL are the most mentioned tickers in articles about GHSI.
Latest GHSI News From Around the Web
Below are the latest news stories about Guardion Health Sciences Inc that investors may wish to consider to help them evaluate GHSI as an investment opportunity.
Guardion Health Sciences, Inc. Announces Closing of $11 Million Public OfferingHOUSTON, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) (“Guardion” or the “Company”), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, today announced the closing of a previously announced public offering of 37,000,000 shares of its common stock (or common stock equivalents in lieu thereof), Class A warrants to purchase up to 37,000,000 shares of its common stock and Class B warrants to purchase up to 37,0 |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayGood morning! |
Guardion Health Sciences, Inc. Announces Pricing of $11 Million Public OfferingHOUSTON, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) (“Guardion” or the “Company”), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, today announced the pricing of a previously announced public offering of 37,000,000 shares of its common stock (or common stock equivalents in lieu thereof), Class A warrants to purchase up to 37,000,000 shares of its common stock and Class B warrants to purchase up to 37,0 |
Guardion Health Sciences, Inc. Announces Proposed Public OfferingHOUSTON, TEXAS, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) (“Guardion” or the “Company”), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, today announced that it intends to offer and sell, shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase shares of common stock in a public offering. All of the securities to be sold in the offering are to be offered by Gua |
Guardion Health Sciences Launches New Viactiv® Omega BOOST™ Passion Fruit Flavored Gel BitesNew Omega BOOST™ Gel Bites Provide 10x More Omega-3 Than Leading Gummies Individually Packaged in Blisterpacks to Ensure Freshness and Portability Omega BOOST™ is the First New Viactiv® Product Launch Since Guardion Acquired the Brand in June 2021 HOUSTON, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, announced the launch of V |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayRise and shine, trader! |
Guardion Health Sciences Launches New Online Store for ViactivNew e-commerce venue to offer all Viactiv products and additional educational content to enhance user experienceHOUSTON, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, today announced the launch of its new branded Shopify store for its Viactiv line of products, https://viactiv.com. The new e-commerce venue offers Viactiv custom |
Guardion Health Sciences to Present at the H.C. Wainwright Bioconnect 2022 Virtual ConferenceHOUSTON, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, announces today that Chief Executive Officer Bret Scholtes will present a corporate overview at the H.C. Wainwright Bioconnect 2022 Virtual Conference, which is taking place on January 10 – 13, 2022. The presentation will be available on-demand to registered attendees of the conference beginning at 7:0 |
Guardion Health Sciences to Wind Down VectorVision Business Operations and Focus on Exploiting VectorVision Intellectual PropertyManagement Anticipates $300,000+ Reduction in Annual Operating CostsHOUSTON, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, announced that, as part of its ongoing comprehensive evaluation of its business, it will wind down the business operations of its VectorVision business and, instead, focus on exploiting its valuable intell |
Guardion Health Sciences Issues Letter to ShareholdersHOUSTON, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a clinical nutrition and diagnostics company that develops clinically supported nutrition, medical foods, supplements, and medical devices, issued the following Letter to Shareholders: Dear Fellow Shareholders, I am delighted to be able to communicate directly with you and share all the developments that have occurred involving Guardion over the last year. During the course of |